Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
Objectives To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods This retrospective multicentric cohort study included patients aged...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/221373 |
| Acceso en línea: | https://hdl.handle.net/2445/221373 |
| Access Level: | acceso abierto |
| Palabra clave: | Neuroimmunologia Autoanticossos Neuroimmunology Autoantibodies |
| id |
ES_80751f8bf490d70bc1c56b4bcd1de9c3 |
|---|---|
| oai_identifier_str |
oai:recercat.cat:2445/221373 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated DiseaseVillacieros Álvarez, JavierEspejo Ruiz, CarmenArrambide, GeorginaDinoto, AlessandroMulero Carrillo, PatriciaRubio Flores, LauraNieto González, PabloAlcalá, CarmenMeca Lallana, José E.Millan Pascual, JorgeMartínez García, PedroBernard Valnet, RaphaelGonzález Suárez, InésOrviz García, AídaTéllez Pérez, RaquelNavarro Cantó, LauraPresas Rodríguez, SilviaMartínez Yélamos, SergioCuello, Juan PabloAlonso Torres, Ana MaríaPiñar Morales, RaquelÁlvarez Bravo, GaryBenyahya, LakhdarTrouillet Assant, SophieDyon Tafan, VirginieFroment Tilikete, CarolineRuet, AurélieBourre, BertrandDeschamps, RomainPapeix, CarolineMaillart, ElisabethKerschen, PhilippeAyrignac, XavierRovira, ÀlexAuger Acosta, CristinaAudoin, BertrandMontalbán Gairín, XavierTintoré Subirana, MarMariotto, SaraCobo Calvo, ÁlvaroMarignier, RomainNeuroimmunologiaAutoanticossosNeuroimmunologyAutoantibodiesObjectives To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods This retrospective multicentric cohort study included patients aged 16 years and older meeting MOGAD 2023 criteria, with serum samples collected at baseline (<= 3 months from disease onset) and follow-up (>= 6 months from the baseline), and age-matched and time to sampling-matched patients with multiple sclerosis (MS). Eleven cytokines were assessed using the ELLA system. Data comparisons and statistical analyses between cytokine levels and clinical outcomes were performed. Results Eighty-eight patients with MOGAD and 32 patients with MS were included. Patients with MOGAD showed higher IL6 (p = 0.036), IL8 (p = 0.012), and IL18 (p = 0.026) baseline levels compared with those with MS, in non-optic neuritis (ON) presentations. BAFF values increased over time, especially in patients with MOGAD treated with anti-CD20 (p = 0.002). Baseline BAFF, CXCL10, IL10, and IL8 levels correlated with disease severity at MOGAD onset (all p < 0.05). Finally, higher baseline BAFF levels predicted lower risk of relapses (hazard ratio 0.41 [0.19; 0.89], p = 0.024). Discussion This study suggests a proinflammatory Th17-dominant profile in non-ON MOGAD patients, with a novel finding of a potential protective role of BAFF on relapses. These results shed new light on the pathogenesis of MOGAD, potentially guiding therapeutic decisions.Ovid Technologies (Wolters Kluwer Health)2025202520252025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion7 p.application/pdfhttps://hdl.handle.net/2445/221373Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1212/NXI.0000000000200362Neurology Neuroimmunology & Neuroinflammation, 2025, vol. 12, num. 2https://doi.org/10.1212/NXI.0000000000200362cc-by (c) Villacieros Álvarez et al., 2025http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2213732026-05-29T05:05:01Z |
| dc.title.none.fl_str_mv |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| title |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| spellingShingle |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease Villacieros Álvarez, Javier Neuroimmunologia Autoanticossos Neuroimmunology Autoantibodies |
| title_short |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| title_full |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| title_fullStr |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| title_full_unstemmed |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| title_sort |
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease |
| dc.creator.none.fl_str_mv |
Villacieros Álvarez, Javier Espejo Ruiz, Carmen Arrambide, Georgina Dinoto, Alessandro Mulero Carrillo, Patricia Rubio Flores, Laura Nieto González, Pablo Alcalá, Carmen Meca Lallana, José E. Millan Pascual, Jorge Martínez García, Pedro Bernard Valnet, Raphael González Suárez, Inés Orviz García, Aída Téllez Pérez, Raquel Navarro Cantó, Laura Presas Rodríguez, Silvia Martínez Yélamos, Sergio Cuello, Juan Pablo Alonso Torres, Ana María Piñar Morales, Raquel Álvarez Bravo, Gary Benyahya, Lakhdar Trouillet Assant, Sophie Dyon Tafan, Virginie Froment Tilikete, Caroline Ruet, Aurélie Bourre, Bertrand Deschamps, Romain Papeix, Caroline Maillart, Elisabeth Kerschen, Philippe Ayrignac, Xavier Rovira, Àlex Auger Acosta, Cristina Audoin, Bertrand Montalbán Gairín, Xavier Tintoré Subirana, Mar Mariotto, Sara Cobo Calvo, Álvaro Marignier, Romain |
| author |
Villacieros Álvarez, Javier |
| author_facet |
Villacieros Álvarez, Javier Espejo Ruiz, Carmen Arrambide, Georgina Dinoto, Alessandro Mulero Carrillo, Patricia Rubio Flores, Laura Nieto González, Pablo Alcalá, Carmen Meca Lallana, José E. Millan Pascual, Jorge Martínez García, Pedro Bernard Valnet, Raphael González Suárez, Inés Orviz García, Aída Téllez Pérez, Raquel Navarro Cantó, Laura Presas Rodríguez, Silvia Martínez Yélamos, Sergio Cuello, Juan Pablo Alonso Torres, Ana María Piñar Morales, Raquel Álvarez Bravo, Gary Benyahya, Lakhdar Trouillet Assant, Sophie Dyon Tafan, Virginie Froment Tilikete, Caroline Ruet, Aurélie Bourre, Bertrand Deschamps, Romain Papeix, Caroline Maillart, Elisabeth Kerschen, Philippe Ayrignac, Xavier Rovira, Àlex Auger Acosta, Cristina Audoin, Bertrand Montalbán Gairín, Xavier Tintoré Subirana, Mar Mariotto, Sara Cobo Calvo, Álvaro Marignier, Romain |
| author_role |
author |
| author2 |
Espejo Ruiz, Carmen Arrambide, Georgina Dinoto, Alessandro Mulero Carrillo, Patricia Rubio Flores, Laura Nieto González, Pablo Alcalá, Carmen Meca Lallana, José E. Millan Pascual, Jorge Martínez García, Pedro Bernard Valnet, Raphael González Suárez, Inés Orviz García, Aída Téllez Pérez, Raquel Navarro Cantó, Laura Presas Rodríguez, Silvia Martínez Yélamos, Sergio Cuello, Juan Pablo Alonso Torres, Ana María Piñar Morales, Raquel Álvarez Bravo, Gary Benyahya, Lakhdar Trouillet Assant, Sophie Dyon Tafan, Virginie Froment Tilikete, Caroline Ruet, Aurélie Bourre, Bertrand Deschamps, Romain Papeix, Caroline Maillart, Elisabeth Kerschen, Philippe Ayrignac, Xavier Rovira, Àlex Auger Acosta, Cristina Audoin, Bertrand Montalbán Gairín, Xavier Tintoré Subirana, Mar Mariotto, Sara Cobo Calvo, Álvaro Marignier, Romain |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Neuroimmunologia Autoanticossos Neuroimmunology Autoantibodies |
| topic |
Neuroimmunologia Autoanticossos Neuroimmunology Autoantibodies |
| description |
Objectives To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods This retrospective multicentric cohort study included patients aged 16 years and older meeting MOGAD 2023 criteria, with serum samples collected at baseline (<= 3 months from disease onset) and follow-up (>= 6 months from the baseline), and age-matched and time to sampling-matched patients with multiple sclerosis (MS). Eleven cytokines were assessed using the ELLA system. Data comparisons and statistical analyses between cytokine levels and clinical outcomes were performed. Results Eighty-eight patients with MOGAD and 32 patients with MS were included. Patients with MOGAD showed higher IL6 (p = 0.036), IL8 (p = 0.012), and IL18 (p = 0.026) baseline levels compared with those with MS, in non-optic neuritis (ON) presentations. BAFF values increased over time, especially in patients with MOGAD treated with anti-CD20 (p = 0.002). Baseline BAFF, CXCL10, IL10, and IL8 levels correlated with disease severity at MOGAD onset (all p < 0.05). Finally, higher baseline BAFF levels predicted lower risk of relapses (hazard ratio 0.41 [0.19; 0.89], p = 0.024). Discussion This study suggests a proinflammatory Th17-dominant profile in non-ON MOGAD patients, with a novel finding of a potential protective role of BAFF on relapses. These results shed new light on the pathogenesis of MOGAD, potentially guiding therapeutic decisions. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 2025 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/221373 |
| url |
https://hdl.handle.net/2445/221373 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1212/NXI.0000000000200362 Neurology Neuroimmunology & Neuroinflammation, 2025, vol. 12, num. 2 https://doi.org/10.1212/NXI.0000000000200362 |
| dc.rights.none.fl_str_mv |
cc-by (c) Villacieros Álvarez et al., 2025 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by (c) Villacieros Álvarez et al., 2025 http://creativecommons.org/licenses/by/3.0/es/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
7 p. application/pdf |
| dc.publisher.none.fl_str_mv |
Ovid Technologies (Wolters Kluwer Health) |
| publisher.none.fl_str_mv |
Ovid Technologies (Wolters Kluwer Health) |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) reponame:Recercat. Dipósit de la Recerca de Catalunya instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str |
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| reponame_str |
Recercat. Dipósit de la Recerca de Catalunya |
| collection |
Recercat. Dipósit de la Recerca de Catalunya |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869411900167553024 |
| score |
15,811543 |